İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2018 · article

Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome

ISSN2053-3721
YÖKSİS OpenAlex Açık erişim · hybrid
Yıl2018
Atıf19OpenAlex
Atıf18Semantic Scholar · 1 etkili
Yüzdelik%77,5
FWCI1,191,00 = dünya ortalaması
Scopus (SJR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJMM Case Reports
  • Katalog eşleşmesi (ISSN)JMM Case Reports
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Introduction. LPS-responsive beige-like anchor (LRBA) protein deficiency is a disease of immune dysregulation with autoimmunity affecting various systems. Case Presentation. Two male siblings with a novel LRBA mutation had different primary findings at admission: the younger sibling had chronic early-onset diarrhoea and the elder one had autoimmune haemolytic anaemia. During long-term follow-up for IPEX phenotype, both developed hypogammaglobulinaemia, enteropathy and lung involvement. The patients partially responded to immunosuppressive therapies. A homozygous c.2496C>A, p.Cys832Ter (p.C832*) mutation in the LRBA gene causing a premature stop codon was detected. After molecular diagnosis, abatacept, as a target-specific molecule, was used with promising results. Conclusion. LRBA deficiency is a recently defined defect, with variable presentations in different patients; a single, definitive treatment option is thus not yet available.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

19atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 19 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2020 Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) scoreAtıf 165 · OpenAlex
  2. 2020 Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) scoreAtıf 165 · OpenAlex
  3. 2019 Hematopoietic Stem Cell Transplantation From Unrelated Donors in 2 Cases of Interleukin-10 Receptor DeficiencyAtıf 162 · OpenAlex
  4. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 162 · OpenAlex
  5. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 162 · OpenAlex
  6. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 162 · OpenAlex
  7. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 162 · OpenAlex
  8. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 162 · OpenAlex
  9. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 153 · OpenAlex
  10. 2019 Abatacept as a Long-Term Targeted Therapy for LRBA DeficiencyAtıf 153 · OpenAlex

Yazarlar

12
  1. Akarcan Sanem Eren 1
  2. Karaca Neslihan Edeer 2
  3. Guzide Aksu 3
  4. Ayca Aykut 4
  5. DENİZ YILMAZ KARAPINAR EGE ÜNİVERSİTESİ 5
  6. Funda Cetin 6
  7. YEŞİM AYDINOK 7
  8. Elif Azarsiz 8
  9. Eleonora Gambineri 9
  10. Ozgur Cogulu 10
  11. Severcan Ezgi Ulusoy 11
  12. Hudaver Alper 12